13F filer · CIK 1179392 ↗
Two Sigma
You are looking at Q3 2021. See the latest, Q2 2026 →
Reported value
$44.75B
+1.5% on the quarter before
Positions
4,175
1,023 new · 808 sold out
Top 10
5.2%
of the value
Est. gain
−$181.7M
on stocks held all quarter
Est. return
−0.8%
on those stocks since Q2 2021
Positions as of Sep 30, 2021, from Two Sigma's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 12% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2021. Striped tiles are options.
Largest buys
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eli Lilly~$230.3MNew · 0.0% → 0.5%+996,910 shares
- PayPal~$230.1MNew · 0.0% → 0.5%+884,227 shares
- Chevron Corp New~$228.0MAdded · 0.0% → 0.5%+2,247,131 shares
- Upstart~$220.3MNew · 0.0% → 0.5%+696,271 shares
- Cisco~$219.7MAdded · 0.0% → 0.5%+4,035,970 shares
- Mastercard~$199.9MAdded · 0.1% → 0.5%+574,918 shares
- SPDR S&P 500 ETF TrPUT~$188.9MAdded · 0.1% → 0.5%+440,100 underlying
- Danaher Corporation~$185.7MNew · 0.0% → 0.4%+609,978 shares
- SPDR S&P 500 ETF TrCALL~$184.8MAdded · 0.0% → 0.4%+430,600 underlying
- Agilent Technologies Inc~$181.7MNew · 0.0% → 0.4%+1,153,653 shares
Largest sells
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pfizer Inc~$231.8MSold out · 0.5% → 0.0%−5,919,331 shares
- Block~$220.7MCut · 0.6% → 0.1%−920,062 shares
- Tjx Cos Inc New~$214.4MSold out · 0.5% → 0.0%−3,179,881 shares
- Canadian Natl Ry Co~$210.5MCut · 0.5% → 0.1%−1,819,787 shares
- Target Corp~$207.9MCut · 0.5% → 0.0%−908,694 shares
- SPDR S&P 500 ETF Tr~$191.1MCut · 0.8% → 0.4%−445,315 shares
- AMD~$185.5MCut · 0.4% → 0.0%−1,802,186 shares
- Roku Inc~$183.7MCut · 0.6% → 0.0%−586,339 shares
- Starbucks Corp~$175.1MCut · 0.5% → 0.1%−1,587,168 shares
- Apple~$174.9MCut · 0.6% → 0.2%−1,236,095 shares
Holdings
As of Sep 30, 2021. Changes are in shares against Jun 30, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AlphabetCAP STK CL A · shares −1.2% · price +9.5% | 0.55% | $245.7M | +$21.3M | ||||||||
| MicrosoftCOM · shares +167% · price +4.1% | 0.54% | $242.7M | +$3.6M | ||||||||
| Caterpillar IncCOM · shares +88% · price −11.8% | 0.53% | $236.0M | −$16.8M | ||||||||
| Visa Inc.COM CL A · shares −2.5% · price −4.7% | 0.53% | $235.1M | −$11.7M | ||||||||
| Citigroup IncCOM NEW · shares +14% · price −0.8% | 0.52% | $231.7M | −$1.6M | ||||||||
| Eli LillyCOM · shares New | 0.51% | $230.3M | — | ||||||||
| PayPalCOM · shares New | 0.51% | $230.1M | — | ||||||||
| Charter Communications Inc NCL A · shares +166% · price +0.8% | 0.51% | $229.7M | +$724,900 | ||||||||
| Chevron Corp NewCOM · shares +16,616% · price −3.2% | 0.51% | $229.3M | −$44,993 | ||||||||
| Booking Holdings IncCOM · shares +35% · price +8.5% | 0.51% | $227.7M | +$13.2M | ||||||||
| Mondelez Intl IncCL A · shares +52% · price −6.8% | 0.51% | $227.3M | −$11.0M | ||||||||
| Amgen IncCOM · shares +13% · price −12.8% | 0.51% | $226.5M | −$29.2M | ||||||||
| Merck & Co IncCOM · shares −6.0% · price −3.4% | 0.50% | $225.5M | −$8.0M | ||||||||
| CiscoCOM · shares +6,899% · price +2.7% | 0.50% | $222.9M | +$83,316 | ||||||||
| IntelCOM · shares +8.4% · price −5.1% | 0.50% | $222.1M | −$11.0M | ||||||||
| SPDR S&P 500 ETF TrPUTTR UNIT · shares +578% | 0.50% | $221.5M | — | ||||||||
| MastercardCL A · shares +939% · price −4.8% | 0.49% | $221.2M | −$1.1M | ||||||||
| Coca Cola CoCOM · shares −6.9% · price −3.0% | 0.49% | $220.7M | −$6.9M | ||||||||
| UpstartCOM · shares New | 0.49% | $220.3M | — | ||||||||
| QualcommCOM · shares −8.3% · price −9.8% | 0.49% | $220.3M | −$23.8M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +0.9% · price −11.4% | 0.49% | $219.2M | −$28.1M | ||||||||
| S&P Global IncCOM · shares +81% · price +3.5% | 0.49% | $219.2M | +$4.1M | ||||||||
| Lam ResearchCOM · shares +485% · price −12.5% | 0.49% | $219.2M | −$5.4M | ||||||||
| Gilead Sciences IncCOM · shares +326% · price +1.4% | 0.49% | $218.3M | +$726,749 | ||||||||
| Philip Morris Intl IncCOM · shares +412% · price −4.4% | 0.48% | $215.7M | −$1.9M | ||||||||
| Total · 4,175 positions | 100% | $44.75B | −$181.7M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2021 to Q3 2021: 1,824 stocks held throughout, down $181.7M (−0.8%).
- Alcoa Corp+$85.0M+4,670%
- Moderna Inc+$75.2M+64%
- Atlassian Corp Plc+$45.2M+52%
- Virgin Galactic Holdings Inc22:1 split+$42.4M+1,110%
- Palo Alto Networks+$34.9M+29%
- Nordstrom Inc−$27.6M−28%
- Baidu−$28.0M−25%
- Bristol-Myers Squibb Co−$28.1M−11%
- Amgen Inc−$29.2M−13%
- Nio Inc−$33.1M−33%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 15 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $138.12B+11% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $123.93B+75% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $70.90B+6% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $67.17B+19% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $56.47B+21% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $46.79B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $45.85B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $45.63B+4% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $43.90B+3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $42.61B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $43.54B+17% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $37.17B−7% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $39.87B+14% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $34.99B+10% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $31.85B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $29.43B−3% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $30.30B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $33.88B−28% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $46.81B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $44.75B+1% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $44.08B+15% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $38.44B+10% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $34.85B+24% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $28.17B+40% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $20.19B+64% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $12.28B−63% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $33.24B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $29.72B−1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $29.90B−3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $30.85B+21% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $25.54B−30% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $36.69B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $33.54B+12% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $30.04B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $30.72B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $28.21B+2% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $27.64B−7% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $29.70B+14% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $26.08B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $27.59B+18% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.29B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $20.99B | SEC ↗ |